IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Nephrocare Health Services Ltd.
Issue Open Date 10-Dec-25  
Issue Closing Date 12-Dec-25  
Application Money 100  
Allotment Money  
Price Band 438 - 460  
Minimium Application No. 32  
Issue Size (Shares) 18935819  
Market Lot 1.00  
Objective
1. Capital expenditure by our Company for opening new dialysis clinics in India and;2. Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by our Company; and 3. General corporate purposes.
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors       NA  
Qualified Institutional Buyers       NA  
Retail Individual Investors       NA  
Business Description
We offer comprehensive dialysis care through our network of clinics – from diagnosis to treatment and wellnessprograms including haemodialysis, home and mobile dialysis, supported by pharmacy. We are India’s largestdialysis service provider in terms of number
more...
Promoter's Holding
Total Share Capital    
Offered to Public   18935819  
Promoter's Holding (Pre-Issue)    
Promoter's Holding (Post-Issue)    
Address
5th Floor
D Block
Ilabs Centre
Plot 18
Software Units Layout
Survey No. 64
Madhapur

Shaikpet
Hyderabad ,
Telangana ,
500081
Phone: 040 4240 8039
Email: cs@nephroplus.com
Website: www.nephroplus.com
Registrar
KFIN Technologies Ltd.
301
The Centrium
3rd Floor
57
Lal Bahadur Shastri Road
Nav Pada
Kurla (West)
Mumbai
Listed at
BSE, NSE
Lead Manager
Ambit Pvt Ltd.
ICICI Securities Ltd
IIFL Capital Services Ltd.
Nomura Financial Advisory & Securities (India) Pvt Ltd.
Promoters
Bessemer Venture Partners Trust
Edoras Investment Holdings PTE. Ltd.
HEALTHCARE PARENT Ltd.
Investcorp Growth Opportunity Fund
Investcorp PVT Equity Fund II
Vikram Vuppala
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.